These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 27976597

  • 1. Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.
    Abrahams KA, Besra GS.
    Parasitology; 2018 Feb; 145(2):116-133. PubMed ID: 27976597
    [Abstract] [Full Text] [Related]

  • 2. Assembly of the Mycobacterial Cell Wall.
    Jankute M, Cox JA, Harrison J, Besra GS.
    Annu Rev Microbiol; 2015 Feb; 69():405-23. PubMed ID: 26488279
    [Abstract] [Full Text] [Related]

  • 3. The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.
    Alderwick LJ, Harrison J, Lloyd GS, Birch HL.
    Cold Spring Harb Perspect Med; 2015 Mar 27; 5(8):a021113. PubMed ID: 25818664
    [Abstract] [Full Text] [Related]

  • 4. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis.
    Kaur D, Guerin ME, Skovierová H, Brennan PJ, Jackson M.
    Adv Appl Microbiol; 2009 Mar 27; 69():23-78. PubMed ID: 19729090
    [Abstract] [Full Text] [Related]

  • 5. Targeting the formation of the cell wall core of M. tuberculosis.
    Barry CE, Crick DC, McNeil MR.
    Infect Disord Drug Targets; 2007 Jun 27; 7(2):182-202. PubMed ID: 17970228
    [Abstract] [Full Text] [Related]

  • 6. Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.
    Jankute M, Grover S, Rana AK, Besra GS.
    Future Microbiol; 2012 Jan 27; 7(1):129-47. PubMed ID: 22191451
    [Abstract] [Full Text] [Related]

  • 7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H.
    Curr Pharm Des; 2014 Jan 27; 20(27):4305-6. PubMed ID: 24245755
    [Abstract] [Full Text] [Related]

  • 8. Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.
    Rombouts Y, Brust B, Ojha AK, Maes E, Coddeville B, Elass-Rochard E, Kremer L, Guerardel Y.
    J Biol Chem; 2012 Mar 30; 287(14):11060-9. PubMed ID: 22315220
    [Abstract] [Full Text] [Related]

  • 9. Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets.
    Alderwick LJ, Birch HL, Mishra AK, Eggeling L, Besra GS.
    Biochem Soc Trans; 2007 Nov 30; 35(Pt 5):1325-8. PubMed ID: 17956343
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
    Bhat ZS, Rather MA, Maqbool M, Lah HU, Yousuf SK, Ahmad Z.
    Biomed Pharmacother; 2017 Nov 30; 95():1520-1534. PubMed ID: 28946393
    [Abstract] [Full Text] [Related]

  • 15. Impact of LytR-CpsA-Psr Proteins on Cell Wall Biosynthesis in Corynebacterium glutamicum.
    Baumgart M, Schubert K, Bramkamp M, Frunzke J.
    J Bacteriol; 2016 Nov 15; 198(22):3045-3059. PubMed ID: 27551018
    [Abstract] [Full Text] [Related]

  • 16. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W, DeJesus MA, Rücker N, Engelhart CA, Wright MG, Healy C, Lin K, Wang R, Park SW, Ioerger TR, Schnappinger D, Ehrt S.
    Antimicrob Agents Chemother; 2017 Dec 15; 61(12):. PubMed ID: 28893793
    [Abstract] [Full Text] [Related]

  • 17. Unraveling the Structure of the Mycobacterial Envelope.
    Daffé M, Marrakchi H.
    Microbiol Spectr; 2019 Jul 15; 7(4):. PubMed ID: 31267927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system.
    Batt SM, Minnikin DE, Besra GS.
    Biochem J; 2020 May 29; 477(10):1983-2006. PubMed ID: 32470138
    [Abstract] [Full Text] [Related]

  • 20. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors.
    Nandi S, Saxena AK.
    Curr Top Med Chem; 2021 May 29; 21(21):1922-1942. PubMed ID: 34315374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.